Oct
2024

VESALIUS FEATURED AT INDONESIA HEALTH EXPO 2024

16 Oct 2024 – This year’s Indonesia Health Expo is held from 16-19 Oct at Jakarta Convention Center. This is the largest exhibition in Indonesia held annually where healthcare professionals congregate to catch up on the latest developments in the industry. Come visit us at Hall B, Booth 56 and experience the most recent version of VESALIUS, designed to be…

Read more

Oct
2024

EyRIS PARTNERS AL-DAWAA IN THE KINGDOM OF SAUDI ARABIA

23 Sep 2024 – We are thrilled to announce EyRIS’ strategic partnership with Al-Dawaa Medical Services Co., one of Saudi Arabia’s premier healthcare distributors. Together, we will bring our advanced AI solutions for retinal and chronic disease detection to the Kingdom, using just a simple fundus image. As chronic conditions continue to rise despite ongoing public health efforts, there is…

Read more

Sep
2024

KASIH IBU HOSPITAL IN TABANAN LATEST TO JOIN VESALIUS ECO-SYSTEM

18 Sep 2024 – Tucked away in central Bali, a distance away from the popular tourist hot-spots is Tabanan – capital town of the regency with the same name. This is exact location of where Kasih Ibu Hospital (KIH) chose to site their 4th hospital to serve a regency with a population of half a million. Over the weekend, KIH…

Read more

Sep
2024

BRUNEI DARUSSALAM TO EMBARK ON NATIONAL DIABETIC RETINOPATHY SCREENING PROGRAM

9 Sep 2024 – Nova MSC is pleased to share that its subsidiary EyRIS has secured an award to rollout SELENA+ as part of the National Diabetic Retinopathy (DR) Screening Program in Brunei Darussalam. Brunei Darussalam is one of the earliest countries in the world to strengthen its public health system by integrating a deep learning system into their national…

Read more

Aug
2024

EYRIS ANNOUNCES STRATEGIC ALLIANCE WITH I-COGNITIO SCIENCES ON ALZHEIMER’S

26 Aug 2024 – EyRIS is thrilled to announce our strategic partnership with @i-Cognitio Sciences (i-cog), a pioneering Hong Kong-based company, to integrate their cutting-edge RetinAD technology into our EySCAN platform. This collaboration represents a major leap forward in non-invasive brain health assessments and early detection of Alzheimer’s risk. RetinAD is an AI-powered tool that analyzes retinal images to deliver…

Read more

Aug
2024

EYRIS HOSTS MEDICAL STUDENTS FROM TSINGHUA UNIVERSITY

8 Aug 2024 – Today, EyRIS had the pleasure of hosting 10 medical students and 2 lecturers from Tsinghua Medicine 清华大学医学院 who were in Singapore as part of their study tour. The stop-over at EyRIS was to provide budding doctors an insight to Singapore’s healthcare start-up eco-system; from clinical research, regulatory hurdles and translational journey. Our team led by Dr…

Read more

May
2024

DIABETES MALAYSIA PARTNERS EYRIS TO DEPLOY SELENA+ FOR RETINAL SCREENING

16 May 2024 –At 18.3% prevalence recorded in 2019, Malaysia worryingly has one of the highest rate of diabetes in the world. It is a major healthcare problem which, if not treated, will lead to other complicated medical conditions, including blindness. Early screening is highly effective in helping to prevent visual complications. Thus, the underlined importance of the role that…

Read more

May
2024

VESALIUS GOES LIVE IN KASIH IBU SABA, BALI

10 May 2024 – On the recent Sunday, VESALIUS – Nova’s hospital information system complete with Electronic Medical Record (EMR) went LIVE in Kasih Ibu Hospital, Saba in Bali. KIH Saba is the 3rd hospital in the group to hop onto the VESALIUS system. From the word get-go in early March, the things moved at breakneck speed. There was hardware…

Read more

May
2024

WILLIAM & MARY | RAYMOND A. MASON SCHOOL OF BUSINESS EMBA COHORT VISITS EYRIS

7 May 2024 – EyRIS had a great day hosting an EMBA delegation from William & Mary | Raymond A. Mason School of Business, a distinguished public research university and the 2nd oldest institution of higher learning located in Williamsburg, Virginia. WM’s Executive MBA is designed for focused, driven leaders who are positioned to move into senior executive and C-suite…

Read more

Apr
2024

SELENA+ ADOPTED AS FIRST MEDICAL AI IN BRUNEI DARUSSALAM

24 Apr 2024 – It is estimated that Brunei Darussalam has a diabetes prevalence of about 13% and evidence reveals that 1 in 3 diabetic patients develops diabetic retinopathy, which left untreated can lead to blindness. This morning, Jerudong Park Medical Centre (JPMC) launched the SELENA+ Artificial Intelligence Diabetic Retinopathy Screening Service – the first AI eye screening service in…

Read more

Apr
2024

SELENA+ IN ACTION DURING DIABETES MALAYSIA AGM

21 Apr 2024 – Nova MSC provided eye screening for the members of Diabetes Malaysia (Penang Branch) during their Annual General Meeting (AGM) in Penang Adventist Hospital (PAH). With the help from Diabetes Malaysia, we have managed to screen more than 20 of their members for eye diseases using SELENA+ an advanced diagnostic tool to autonomously detect diabetic retinopathy, glaucoma…

Read more

Apr
2024

EYRIS PARTICIPATES IN DIABETIC RETINOPATHY SCREENING INITIATIVE IN MONGOLIA

15 Apr 2024 – EyRIS is thrilled to announce our partnership with iCare in support of Sight For All’s mission to combat preventable blindness in Mongolia. We are humbled to be invited to participate in this meaningful community outreach project by way of contributing our flagship product SELENA+, an advanced diagnostic tool to autonomously detect diabetic retinopathy, glaucoma and Aged-Related…

Read more